AADR vs CHNA

AADR is an ETF, whereas CHNA is a mutual fund. AADR has a higher expense ratio than CHNA (1.1% vs 0.79%). Below is the comparison between AADR and CHNA.

	AADR	CHNA
Security Type	ETF	Mutual fund
Segment	Equity: Global Ex-U.S. - Total Market Growth	N/A
Issuer	AdvisorShares	Loncar Investments
Net Assets	$69.25M	$10.5M
Expense Ratio	1.10%	0.79%
Management Style	passive (index-based)	passive
Dividend Yield	0.68%	0.15%
Minimum Investment	N/A	N/A
YTD Return	2.78%	24.32%
1-Year Return	11.52%	33.56%
3-Year Return	1.81%	N/A
5-Year Return	9.50%	N/A
10-Year Return	8.38%	N/A

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return	2.78%
1-Month Return	-4.57%
3-Month Return	10.80%
1-Year Return	11.52%
3-Year Return	1.81%
5-Year Return	9.50%
10-Year Return	8.38%

AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (46.22% of Total Assets)

Name	Symbol	% Assets
MercadoLibre Inc	MELI.SA	5.89%
argenx SE ADR	ARGX	5.63%
NICE Ltd ADR	NICE	5.45%
Gold Fields Ltd ADR	GFI.JO	5.07%
Galapagos NV ADR	GLPG	4.76%
Anglogold Ashanti Ltd ADR	AU.JO	4.67%
ZTO Express (Cayman) Inc ADR	ZTO	4.27%
TAL Education Group ADR	TAL	3.75%
ASML Holding NV ADR	ASML	3.67%
AstraZeneca PLC ADR	AZN.L	3.06%

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

CHNA description

The Fund seeks to track the performance of the Loncar China BioPharma Index. The Fund invests at least 80% of its assets in the component securities of the Index constructed from the universe of Nasdaq- or Hong Kong Stock Exchange-listed companies identified by the Index methodology as Biopharma Companies.

CHNA performance & returns

YTD Return	24.32%
1-Month Return	-6.34%
3-Month Return	10.11%
1-Year Return	33.56%
3-Year Return	N/A
5-Year Return	N/A
10-Year Return	N/A

CHNA expense ratio is 0.79%.

CHNA holdings

Top 10 Holdings (43.63% of Total Assets)

Name	Symbol	% Assets
CanSino Biologics Inc Class H	06185	6.51%
Shanghai Junshi Biosciences Co Ltd Class H	01877	5.26%
Wuxi AppTec Co Ltd	02359	4.35%
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S	02269	4.24%
Sino Biopharmaceutical Ltd	01177.HK	4.10%
Innovent Biologics Inc	01801	4.09%
I-MAB ADR	IMAB	4.07%
Hansoh Pharmaceutical Group Co Ltd	03692	3.95%
BeiGene Ltd ADR	BGNE	3.61%
Zai Lab Ltd ADR Repr 1 Shs	ZLAB	3.45%

Other relevant CHNA comparisons

You may also want to check out the following CHNA comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.